Sigbjørn Berentsen

4.9k total citations · 1 hit paper
80 papers, 2.7k citations indexed

About

Sigbjørn Berentsen is a scholar working on Hematology, Physiology and Genetics. According to data from OpenAlex, Sigbjørn Berentsen has authored 80 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 69 papers in Hematology, 46 papers in Physiology and 24 papers in Genetics. Recurrent topics in Sigbjørn Berentsen's work include Blood groups and transfusion (66 papers), Erythrocyte Function and Pathophysiology (46 papers) and Chronic Lymphocytic Leukemia Research (19 papers). Sigbjørn Berentsen is often cited by papers focused on Blood groups and transfusion (66 papers), Erythrocyte Function and Pathophysiology (46 papers) and Chronic Lymphocytic Leukemia Research (19 papers). Sigbjørn Berentsen collaborates with scholars based in Norway, United Kingdom and Italy. Sigbjørn Berentsen's co-authors include Geir E. Tjønnfjord, Wilma Barcellini, Elling Ulvestad, Ulla Randen, Klaus Beiske, Anita Hill, Quentin A. Hill, Bernd Jilma, Marc Michel and Alexander Röth and has published in prestigious journals such as New England Journal of Medicine, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Sigbjørn Berentsen

78 papers receiving 2.7k citations

Hit Papers

Diagnosis and treatment of autoimmune hemolytic anemia in... 2019 2026 2021 2023 2019 50 100 150 200 250
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Diagnosis and treatment of autoimmune hemolytic anemia in adults: Recommendations from the First International Consensus Meeting
    2019 286 citations Wilma Barcellini, Catherine M. Broome et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sigbjørn Berentsen Norway 29 2.3k 1.6k 734 701 506 80 2.7k
Gregory A. Denomme United States 26 1.7k 0.7× 881 0.6× 537 0.7× 170 0.2× 364 0.7× 110 2.3k
Olga Núñez United States 18 1.8k 0.8× 297 0.2× 399 0.5× 619 0.9× 309 0.6× 29 2.2k
Pascale Loiseau France 22 412 0.2× 273 0.2× 190 0.3× 753 1.1× 214 0.4× 45 1.6k
Frances M. Gibson United Kingdom 20 755 0.3× 244 0.2× 314 0.4× 383 0.5× 160 0.3× 56 1.4k
Kazuo Sakashita Japan 20 446 0.2× 251 0.2× 174 0.2× 386 0.6× 165 0.3× 125 1.4k
AA Fauser Germany 22 1.6k 0.7× 175 0.1× 469 0.6× 490 0.7× 134 0.3× 63 2.1k
Britta Höchsmann Germany 21 838 0.4× 122 0.1× 429 0.6× 988 1.4× 93 0.2× 65 1.6k
J. J. van Loghem Netherlands 19 814 0.4× 309 0.2× 167 0.2× 310 0.4× 342 0.7× 82 1.4k
Hirohito Yamazaki Japan 21 1.0k 0.4× 68 0.0× 240 0.3× 692 1.0× 130 0.3× 95 1.4k
Cécile Kaplan France 26 1.5k 0.7× 81 0.1× 109 0.1× 194 0.3× 707 1.4× 76 1.9k

Countries citing papers authored by Sigbjørn Berentsen

Since Specialization
Citations

This map shows the geographic impact of Sigbjørn Berentsen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sigbjørn Berentsen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sigbjørn Berentsen more than expected).

Fields of papers citing papers by Sigbjørn Berentsen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sigbjørn Berentsen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sigbjørn Berentsen. The network helps show where Sigbjørn Berentsen may publish in the future.

Co-authorship network of co-authors of Sigbjørn Berentsen

This figure shows the co-authorship network connecting the top 25 collaborators of Sigbjørn Berentsen. A scholar is included among the top collaborators of Sigbjørn Berentsen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sigbjørn Berentsen. Sigbjørn Berentsen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Berentsen, Sigbjørn. (2024). Cold-antibody Autoimmune Hemolytic Anemia: its Association with Neoplastic Disease and Impact on Therapy. Current Oncology Reports. 26(9). 1085–1096. 2 indexed citations
2.
Małecka, Agnieszka, Gunhild Trøen, Jędrzej Małecki, et al.. (2023). Gene expression analysis revealed downregulation of complement receptor 1 in clonal B cells in cold agglutinin disease. Clinical & Experimental Immunology. 216(1). 45–54. 6 indexed citations
3.
Röth, Alexander, Wilma Barcellini, Shirley D’Sa, et al.. (2023). Sustained inhibition of complement C1s with sutimlimab over 2 years in patients with cold agglutinin disease. American Journal of Hematology. 98(8). 1246–1253. 16 indexed citations
4.
Hansen, Dennis Lund, Margaux Lafaurie, Sören Möller, et al.. (2023). Primary autoimmune haemolytic anaemia is associated with increased risk of ischaemic stroke: A binational cohort study from Denmark and France. British Journal of Haematology. 204(3). 1072–1081. 1 indexed citations
5.
Berentsen, Sigbjørn. (2023). Sutimlimab for the Treatment of Cold Agglutinin Disease. HemaSphere. 7(5). e879–e879. 6 indexed citations
6.
Berentsen, Sigbjørn & Geir E. Tjønnfjord. (2022). Current Treatment Options in Cold Agglutinin Disease: B-Cell Directed or Complement Directed Therapy?. Transfusion Medicine Reviews. 36(4). 181–187. 7 indexed citations
7.
Berentsen, Sigbjørn, Wilma Barcellini, Shirley D’Sa, et al.. (2021). Inhibition of Complement C1s By Sutimlimab in Patients with Cold Agglutinin Disease (CAD): Efficacy and Safety Results from the Randomized, Placebo-Controlled Phase 3 CADENZA Study. Blood. 138(Supplement 1). 349–349. 6 indexed citations
8.
Berentsen, Sigbjørn & Wilma Barcellini. (2021). Autoimmune Hemolytic Anemias. New England Journal of Medicine. 385(15). 1407–1419. 114 indexed citations
9.
Berentsen, Sigbjørn. (2020). New Insights in the Pathogenesis and Therapy of Cold Agglutinin-Mediated Autoimmune Hemolytic Anemia. Frontiers in Immunology. 11. 590–590. 86 indexed citations
10.
Berentsen, Sigbjørn, et al.. (2019). Cold agglutinin disease: current challenges and future prospects. SHILAP Revista de lepidopterología. 1 indexed citations
11.
Berentsen, Sigbjørn. (2018). How I manage patients with cold agglutinin disease. British Journal of Haematology. 181(3). 320–330. 60 indexed citations
12.
Berentsen, Sigbjørn. (2016). Cold agglutinin disease. Hematology. 2016(1). 226–231. 73 indexed citations
13.
Berentsen, Sigbjørn. (2015). Role of Complement in Autoimmune Hemolytic Anemia. Transfusion Medicine and Hemotherapy. 42(5). 303–310. 48 indexed citations
14.
Randen, Ulla, Gunhild Trøen, Anne Tierens, et al.. (2013). Primary cold agglutinin-associated lymphoproliferative disease: a B-cell lymphoma of the bone marrow distinct from lymphoplasmacytic lymphoma. Haematologica. 99(3). 497–504. 108 indexed citations
15.
Berentsen, Sigbjørn. (2011). How I manage cold agglutinin disease. British Journal of Haematology. 153(3). 309–317. 59 indexed citations
16.
Berentsen, Sigbjørn, et al.. (2009). Autoimmun hemolytisk anemi. Tidsskrift for Den norske legeforening. 129(21). 2226–2231. 1 indexed citations
17.
Berentsen, Sigbjørn, Elling Ulvestad, & Geir E. Tjønnfjord. (2007). B-lymphocytes as Targets for Therapy in Chronic Cold Agglutinin Disease. Cardiovascular & Haematological Disorders - Drug Targets. 7(3). 219–227. 9 indexed citations
18.
Berentsen, Sigbjørn, Geir E. Tjønnfjord, Robert Brudevold, et al.. (2001). Favourable response to therapy with the anti‐CD20 monoclonal antibody rituximab in primary chronic cold agglutinin disease. British Journal of Haematology. 115(1). 79–83. 82 indexed citations
19.
Tangen, Jon‐Magnus, et al.. (1999). [Empirical antibiotic treatment of patients with acute myelogenous leukemia].. PubMed. 119(1). 35–8. 2 indexed citations
20.
Berentsen, Sigbjørn, et al.. (1990). [Visceral leishmaniasis (kala-azar)].. PubMed. 110(27). 3491–3. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gregory A. Denomme Breakdown of academic impact, for papers by Olga Núñez Breakdown of academic impact, for papers by Pascale Loiseau Breakdown of academic impact, for papers by Frances M. Gibson Breakdown of academic impact, for papers by Kazuo Sakashita Breakdown of academic impact, for papers by AA Fauser Breakdown of academic impact, for papers by Britta Höchsmann Breakdown of academic impact, for papers by J. J. van Loghem Breakdown of academic impact, for papers by Hirohito Yamazaki Breakdown of academic impact, for papers by Cécile Kaplan
Rankless by CCL
2026